CLDN4 and endometrial cancer: In this study, we investigated the expression and the clinical values of SPTBN2 in endometrial cancer, and we mainly explored the biological functions and the potential interaction among miR-424-5p, SPTBN2 and CLDN4, and identified their effects on progression in endometrial cancer.